Cannabis-Derived drug tested for stubborn heart inflammation
NCT ID NCT05494788
Summary
This small, completed pilot study tested whether a purified cannabidiol (CBD) drug could help control recurrent pericarditis, a painful inflammation of the heart's lining. It involved 27 adults whose condition was not well-controlled by standard medications. The main goals were to check the drug's safety and see if it could reduce pain and allow patients to reduce their use of steroids.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT PERICARDITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
MedStar Health Research Institute
Washington D.C., District of Columbia, 20010, United States
-
Minneapolis Heart Institute Foundation
Minneapolis, Minnesota, 55407, United States
-
Pima Heart and Vascular Clinical Research
Tucson, Arizona, 85719, United States
-
University of Vermont Medical Center
Burlington, Vermont, 05401, United States
-
Virginia Commonwealth University Health
Richmond, Virginia, 23298, United States
Conditions
Explore the condition pages connected to this study.